novartis

Yikes! Switzerland just refused to enforce E.U. sanctions against Russian subsidiaries! Here's a free P.S.A.: As the U.S.A. and its allies pivot to a war economy, it may start to be hard to work at companies owned by our enemies (their revenue supports their war effort). Those companies may...

Curious on thoughts of when this deal will finalize and what the outcome looks like. Will territories change? What products will we carry? What's the within 10% look like?

And I’m out Dear "lucky-to-be-staying" colleagues, In a shocking twist of fate, I've been granted the exclusive opportunity to depart from Novartis! That's right – after years of tireless devotion, sacrificing weekends, and practically living at the office or in Teams/Outlook from home, I've...

Ok let’s cut to the chase here. We know lay off are happening soon. Leqvio is doing beyond horrible. Entrestos patent ends in 2 years. Duane’s answer in Dallas regarding lay offs was a joke. Does anyone else see the writing on the wall? Or you all naive?

Guys - my function was lift and shift but downsizing because people are leaving. It is suffocating with increased workload and job responsibility changed to operation and metrics rather than scientific discussion. I hate it. I wish I could get severance package… is it too late? Is there any...

Any Ashfield reps working with Novartis currently? What are the base salaries for inside sales

Anyone know anything about this call for optha on 11/17? Feels like we just had a call like this. Why another one so soon??

Former GSK rep here. Just talked to a few friends at Novartis who are genuinely concerned about their futures with the company. Speaking from experience run, don’t walk to find a new job. Dez will single handedly suck the soul of every last one of you by instilling so many trackers and metrics...

Rumblings that Novartis layoffs are to make room for Clovis onc acquisition of 400+ employees, to be announced. I assume the reason being Nvs interested in FAP-2286 and owns the rights to "Lumiere" anyway. Anyone have an inkling?

What’s up with Syneos Talent Acquisition??? They stalk you. Ask the dumbest questions in the world and no zero about the products? Then they ghost. LOL.

I wonder when the layoffs will start. Doctors are not going to let reps back in until mid summer at the earliest, if at all.

Novartis on Thursday surprised Wall Street by reporting a year-over-year increase in net earnings in Q2, helped by higher sales and a one-time divestment gain. The company said its earnings grew 14% to $1.34 per share, even as analysts were anticipating a decline. Riding on the strong sales of...

Which Pharma will get their hands on this. Zemdri now FDA approved and exclusivity at least to 2031 or 2032 and EMA approval ahead Roche. ...Pfizer. ...Sanofi. ... Merck. ... GSK (GlaxoSmithKline) ...AstraZeneca. ...Bayer...Johnson & Johnson. who will outbid who

What's the reason for Celgene going down even after beating the estimates and lifting 2018 outlook? Any thoughts? https://news.alphastreet.com/celgene-celg-stock-q3-2018-earnings/

After announcing positive results for the treatment of cystic fibrosis, Proteostasis Therapeutics stock skyrocketed more than 400% and reached the double-digit mark after 18 months. https://news.alphastreet.com/proteostasis-therapeutics-stock-skyrockets-on-positive-cystic-fibrosis-trial-results/

Novartis AG reported a 22% dip in earnings for the third quarter due to charges from the voluntary withdrawal of CyPass, higher restructuring, and discontinuation of GSK consumer healthcare joint venture. The top and bottom line came in ahead of analysts’ expectations. In a separate release...

Dear Novartis employees, How many of us have been faced with endless compliance training yet we see before us on a regular basis how Novartis management violate laws and ethics across the world? Well now is the time to start fixing this and to build a database of evidence that can be used to...

Celgene's second quarter results beat estimates and the company lifted 2018 outlook. Celgene will not be increasing the price of its products this year. https://news.alphastreet.com/celgene-q2-2018-earnings/

Investors have welcomed the move of Eli Lilly's decision to separate Elanco Animal Health business. Lilly stock hits a new 52-week high after the earnings announcement. David Ricks said, "As the responses to the Blueprint are considered, we are hopeful that progress will be made on implementing...

Trump has been speaking and tweeting about the higher drug prices for nearly two years and still he has not taken any steps in reducing the prices of the drugs. Pfizer and other pharma companies are taking advantage and increasing their drug prices often. When will this stop...